StockWatch
·
Pharmaceuticals
Corporate Governance17 Nov 2026, 10:18 am

Ajanta Pharma: Revised Promoter Share Pledge Disclosure

AI Summary

Ajanta Pharma Limited has filed revised disclosures regarding the creation of encumbrances on promoter shares under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The revisions clarify the entities in whose favor shares have been encumbered, specifically naming both the lender and the trustee, as required by regulations. This update addresses a discrepancy noted by BSE and ensures compliance with disclosure norms. The core information regarding the number of shares pledged and the dates of creation remains consistent with the original filings.

Key Highlights

  • Revised promoter share pledge disclosures filed with SEBI.
  • Clarifies lender and trustee names for encumbered shares.
  • Addresses BSE discrepancy regarding disclosure details.
  • Ensures compliance with SEBI (SAST) Regulations, 2011.
  • No modification to original number of shares pledged.